Payment & Shipping Terms:
|Name:||Ticagrelor||Synonym:||AZD - 6140|
274693 27 5,
1377049 84 7
Ticagrelor AZD - 6140 CAS : 274693-27-5 GMP DMF
Name : Ticagrelor
CAS No . : 274693-27-5
Synonym : AZD - 6140
Chemical Name : ( 1S , 2S , 3R , 5S ) - 3 - [ 7 - [ ( 1R , 2S ) - 2 - ( 3 , 4 - Difluorophenyl ) cyclopropylamino ] - 5 - ( propylthio ) - 3H - [ 1 , 2 , 3 ] triazolo [ 4 , 5-d ] pyrimidin - 3 - yl ] - 5 - ( 2 - hydroxyethoxy ) cyclopentane - 1 , 2 - diol
Molecular Formula : C23H28F2N6O4S
Molecular Weight : 522.57
Ticagrelor is the active pharmaceutical ingredients (API) of branded drug Brillinta, Briliquie and Possia. It was approved in December 3 2010 in Euorpe and in July 2011in USA by FDA . It is marketed by AstraZeneca. Ticagrelor is a platelet aggregation inhibitor and used to prevent thrombotic events such as stroke or heart attack in people with acutate coronary syndrome or myocardial infarction with ST elevation. Ticagrelor is better than clopidogrel for P2Y12 inhibition treatment in patients with NSTE-ACS treated with early invasive strategy and/or coronary stenting according to AHA/ACC Guidelines (09/2014).
The drug might be protected by patents in some courtires or areas. We only sell it to non patent protected countries or areas. The sale to patent protection countries and areas is only for R & D purpose. The buyers should take all responsiblity of patent status in his countries or areas.
Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.